Compare Humana Inc (HUM) vs Phillips 66 (PSX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Phillips 66 — how do they compare? Humana Inc trades at $405.62 (market cap $47.81B), while Phillips 66 trades at $210.42 (market cap $83.72B). The key difference: Phillips 66 is the larger of the two by market cap, and Phillips 66 pays the higher dividend (2.43%). Which is the better fit depends on your goals.
| HUM | PSX | |
|---|---|---|
Market Cap | $47.81B | $83.72B |
Sector | Health | Energy |
52-Week High | $409.42 | $208.80 |
52-Week Low | $163.67 | $118.37 |
Enterprise Value | $56.85B | $105.69B |
Dividend Yield | 0.89% | 2.43% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
PSX trades at $209.47, up 1.26% on the day, with strong technical momentum and bullish moving average signals. The stock benefits from elevated refining margins and has beaten earnings expectations in three consecutive quarters. Recent news highlights its advantage from tight fuel markets and Middle East supply dynamics, while the company maintains a solid dividend payout of $1.27 per share.
Outlook remains positive with 57% analyst buy ratings and a consensus price target of $201.50, though current price exceeds this. Risks include volatile oil prices and declining revenue trends from $170B in 2022 to $132.4B in 2025. Institutional sentiment is supported by efficient refining operations and strategic positioning in current energy markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Phillips 66
Phillips 66 is an independent refiner with 12 refineries that have a total crude throughput capacity of 2.0 million barrels per day, or mmb/d, after converting its 255 mb/d Alliance refinery to a terminal. The midstream segment comprises extensive transportation and NGL processing assets. It also includes its DCP Midstream joint venture, which holds 45 natural gas processing facilities, 11 NGL fractionation plants, and a natural gas pipeline system with 58,000 miles of pipeline. Its CPChem chemical joint venture operates facilities in the United States and the Middle East and primarily produces olefins and polyolefins.
Read more on PSX →
